Your browser doesn't support javascript.
loading
Generation of CD20-specific TCRs for TCR gene therapy of CD20low B-cell malignancies insusceptible to CD20-targeting antibodies.
Jahn, Lorenz; van der Steen, Dirk M; Hagedoorn, Renate S; Hombrink, Pleun; Kester, Michel G D; Schoonakker, Marjolein P; de Ridder, Daniëlle; van Veelen, Peter A; Falkenburg, J H Frederik; Heemskerk, Mirjam H M.
Afiliación
  • Jahn L; Department of Hematology, Leiden University Medical Center, 2300 RC Leiden, The Netherlands.
  • van der Steen DM; Department of Hematology, Leiden University Medical Center, 2300 RC Leiden, The Netherlands.
  • Hagedoorn RS; Department of Hematology, Leiden University Medical Center, 2300 RC Leiden, The Netherlands.
  • Hombrink P; Department of Hematology, Leiden University Medical Center, 2300 RC Leiden, The Netherlands.
  • Kester MG; Department of Hematopoiesis, Sanquin Research, 1006 AD Amsterdam, The Netherlands.
  • Schoonakker MP; Department of Hematology, Leiden University Medical Center, 2300 RC Leiden, The Netherlands.
  • de Ridder D; Department of Hematology, Leiden University Medical Center, 2300 RC Leiden, The Netherlands.
  • van Veelen PA; Department of Hematology, Leiden University Medical Center, 2300 RC Leiden, The Netherlands.
  • Falkenburg JH; Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, 2300 RC Leiden, The Netherlands.
  • Heemskerk MH; Center for Proteomics and Metabolomics, Leiden University Medical Center, 2300 RC Leiden, The Netherlands.
Oncotarget ; 7(47): 77021-77037, 2016 Nov 22.
Article en En | MEDLINE | ID: mdl-27776339

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Receptores de Antígenos de Linfocitos T / Leucemia de Células B / Linfoma de Células B / Antígenos CD20 Límite: Humans Idioma: En Revista: Oncotarget Año: 2016 Tipo del documento: Article País de afiliación: Países Bajos Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Receptores de Antígenos de Linfocitos T / Leucemia de Células B / Linfoma de Células B / Antígenos CD20 Límite: Humans Idioma: En Revista: Oncotarget Año: 2016 Tipo del documento: Article País de afiliación: Países Bajos Pais de publicación: Estados Unidos